Clinical Information

The safety and effectiveness of the Mynx Vascular Closure Device was evaluated in patients following diagnostic and interventional procedures performed through 6F or 7F introducer sheaths located in the common femoral artery.

The Mynx Study
The study was a prospective, multi-center, non-randomized clinical investigation conducted at 5 European centers. Patient enrollment included 190 patients with 50% of patients having undergone diagnostic catheterization and 50% interventional procedures.

The primary safety endpoint was the combined rate of major complications within 30 days. The primary efficacy endpoints were time to hemostasis and time to ambulation.

Key Results from the Mynx Study:

• 0.5% rate of major complications
• Absence of complications requiring surgical repair
• Rapid hemostasis (mean 1.3 minutes) independent of anticoagulation
• Time to hemostasis comparable whether the patient underwent a diagnostic (median 0.5 minutes) or interventional (median 0.6 minutes) procedure
• Consistently rapid time to ambulation of 2.0 hours for diagnostic patients and 1.9 hours for interventional patients

Mynx Study Conclusions:

• Demonstrated safety and efficacy
• Extravascular, water-soluble sealant offering unique safety profile
• Rapidly resorbs, leaving nothing behind
• Potential for clinical versatility – PVD, immediate restick, obesity

---

View published clinical articles about the Mynx:
Note: AccessClosure, Inc. is not responsible for the content presented in the following links and websites.

• TCTMD: Successful 24-Hour Repuncture and Reclosure of the Common Femoral Artery with the Mynx Vascular Closure Device
• TCTMD: Lack of Scarring and Inflammation Observed During Endovascular Repair of an Abdominal Aortic Aneurysm (AAA) 27 Days Following Use of the Mynx Vascular Closure Device
• TCTMD: Successful 24-Hour Re-Stick in an Anticoagulated AMI Patient with the Mynx Vascular Closure Device
• TCTMD: Mynx Closure in a Patient Treated for Chronic Total Occlusion of the Iliac Artery with Multiple Sheath Exchanges
  
• Endovascular Today: The Mynx Vascular Closure Device: Initial clinical experience using a novel approach to vascular closure
• Endovascular Today: The Mynx Vascular Closure Device: Adopting extravascular closure technology in the catheterization lab